Abstract
We investigated the ability of several recent clinical viridans group streptococci (VGS) bloodstream isolates (Streptococcus mitis/S. oralis subgroup) from daptomycin (DAP)-naive patients to develop DAP resistance in vitro. All strains rapidly developed high-level and stable DAP resistance. Substitutions in two enzymes involved in the cardiolipin biosynthesis pathway were identified, i.e., CdsA (phosphatidate cytidylyltransferase) and PgsA (CDP-diacylglycerol-glycerol-3-phosphate-3phosphatidyltransferase). These mutations were associated with complete disappearance of phosphatidylglycerol and cardiolipin from cell membranes. DAP interactions with the cell membrane differed in isolates with PgsA versus CdsA substitutions.
Original language | English (US) |
---|---|
Article number | e01531-18 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 63 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2019 |
Keywords
- CdsA
- Daptomycin resistance
- PgsA
- Streptococcus mitis
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases